Tumor Markers in Oral Cancer
Journal of Cancer Immunology and therapy is an peer-reviewed, open-access scholarly journal focused on publishing articles in all aspects of academic journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.
Oral cavity cancer is amongst the most prevalent cancers worldwide and incidence rates are higher in men than women. There are an estimated 529,000 new cases of cancers of the oral cavity and pharynx each year, and more than 300,000 deaths. Oral cancers include the main subsites of lip, oral cavity, nasopharynx and pharynx and have a particularly high burden in South Central Asia due to risk factor exposures.
Tumor markers are substances that are produced either by the tumor itself or by the body in response to the presence of cancer or certain benign conditions that can aid in the diagnosis of cancer. These markers may be employed to predict primary or secondary tumor risk. Sometimes, non-cancerous conditions can also cause elevation of some tumor markers to be higher than normal. Besides, not every cancer patient may have raised level of a tumor marker. For these reasons, knowledge about cancer biomarkers is essential. This review highlights potential molecular markers relevant to oral neoplasia in terms of their perspective role of in prevention and detection.
The journal serves as a forum for new concepts and advances in basic Cancer Discovery, Epidemiology, Biomarkers & Prevention Cancer Surgery, Types of Cancers, Various methods in cancer treatment. Papers are stringently reviewed, Chief criteria for acceptance are scientific novelty and quality, originality, and clarity with early online publication, regular podcasts and an immense archive collection.
Submit manuscripts as an email attachment to the Email: email@example.com
Journal of Cancer Immunology and Therapy
Whats App: +1-97-333-4405